Ketu Medicine is an anti-tumor drug developer. Based on drug sensitivity models, pharmacokinetic models, drug metabolism models and biomarkers, it can predict the response of drugs in the user’s body, so as to carry out personalized drug dose selection and administration. formulation of the plan. Recently, Ketu Medical completed a new round of financing of tens of millions of yuan. This round of financing was invested by Fangfu Capital, and Zhongguancun Industrial Research Institute served as the exclusive financial advisor. Funds from this round of financing are mainly used for preclinical toxicology and pharmacology platform upgrade, multi-dimensional data mining of organoids and market expansion.
This article is reproduced from: https://www.itjuzi.com/investevent/13444361
This site is for inclusion only, and the copyright belongs to the original author.